[1] 颜慕霞.巨细胞病毒感染与儿童免疫性血小板减少性紫癜的关系探讨[J].热带医学杂志, 2011, 11(7):778-780.
[2] 张之南,沈悌.血液病诊断及疗效标准[M].3版.北京:科学出版社,2007:172-175.
[3] Provan D,Stasi R,Newland AC,et al.International consensus report on the investigation and management of primary immune thrombocytopenia[J].Blood,2010,115(2):168-186.
[4] 王玲,李华伟.117例特发性血小板减少性紫癜临床资料分析[J].医学信息, 2011, 24(11):100.
[5] 张惠荣, 宁建英, 杨红.特发性血小板减少性紫癜T淋巴细胞亚群和免疫球蛋白变化[J].实用儿科临床杂志, 2004, 19(5):361-362.
[6] Yu H,Liu Y,Han J,et al.TLR7 regulates dendritic cell-dependent B-cell responses through BlyS in immune thrombocytopenic purpura[J].Eur J Haematol,2011(86):67-74.
[7] Yujiri T,Tanaka Y,Tanaka M.56 Alteration in serum B cell-activating factor levels inpatients with idiopathic thrombocytopenic purpura after Helicobacter pylori eradication therapy[J].Br J Haematol,2011,152(4):496-498.
[8] Abdel-Hamid SM,Al-Lithy HN.B cell activating factor gene polymorphisms in patients with risk of idiopathic thrombocytopenic purpura[J].Am J Med Sci,2011,342(1):9-14.
[9] 李美玲,杨林花,朱镭.T淋巴细胞亚群在特发性血小板减少性紫癜患者中的表达及意义[J].中国药物与临床,2011,11(4):408-409.
[10] 甘思林,孙慧,张秋堂.淋巴细胞亚群在成人特发性血小板减少性紫癜中的变化及临床意义[J].临床血液学杂志,2009,22(9):500-501.